Skip to content

Apotheek Vandromme: what changed

BE 0875.953.748NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€186,973
2024 · €138,401+€48,572
Equity
€590,053
2024 · €404,745+€185,307
Cash
€72,224
2024 · €30,683+€41,541
Balance sheet total
€1.4m
2024 · €1.3m+€26,708

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€86,792

    down €86,792 (-8.3%), from €1.0m to €962,719

    of which Land and buildings: -€82,431

  • Receivables within one year +€74,311

    up €74,311 (+103%), from €72,098 to €146,408

    of which Trade receivables: +€65,523

  • Cash +€41,541

    up €41,541 (+135%), from €30,683 to €72,224

    mainly Net result for the year (+€186,973) and Depreciation (+€92,016)

Equity and liabilities
  • Reserves +€185,307

    up €185,307 (+55.9%), from €331,336 to €516,643

  • Current portion of long-term debt -€75,219

    down €75,219 (-53.1%), from €141,651 to €66,432

  • Debts after one year -€66,432

    down €66,432 (-16.5%), from €401,919 to €335,487

  • Other debts -€50,313

    down €50,313 (-17.9%), from €281,233 to €230,920

  • Tax, wage and social debts +€30,983

    up €30,983 (+179%), from €17,286 to €48,269

    of which Taxes: +€26,814

Income statement
  • Gross operating margin +€107,774

    up €107,774 (+29.0%), from €371,705 to €479,479

  • Staff costs +€42,606

    up €42,606 (+147%), from €28,902 to €71,508

  • Taxes +€22,254

    up €22,254 (+35.2%), from €63,142 to €85,396

  • Depreciation -€13,372

    down €13,372 (-12.7%), from €105,388 to €92,016

  • Financial charges +€7,853

    up €7,853 (+24.8%), from €31,685 to €39,538

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €138,401
Gross operating margin +€107,774
Staff costs -€42,606
Depreciation +€13,372
Other operating charges +€369
Financial income -€230
Financial charges -€7,853
Taxes -€22,254
Result 2025 €186,973
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€190,083
Investment -€5,224
Financing -€143,317
Cash 2024 €30,683
Net result for the year +€186,973
Depreciation +€92,016
Stocks and contracts +€2,239
Receivables within one year -€74,311
Deferred charges and accrued income +€112
Trade debts -€4,314
Tax, wage and social debts +€30,983
Other debts -€50,313
Accrued charges and deferred income +€6,697
Investment in fixed assets (net) -€5,224
Debts after one year -€66,432
Current portion of long-term debt -€75,219
Contributions, distributions and other -€1,666
Cash 2025 €72,224
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,325,564 €1,352,273 +€26,708 +2.0%
Fixed assets 21/28 €1,049,511 €962,719 -€86,792 -8.3%
Tangible fixed assets 22/27 €1,049,511 €962,719 -€86,792 -8.3%
Land and buildings 22 €1,027,012 €944,582 -€82,431 -8.0%
Plant, machinery and equipment 23 €5,551 €4,462 -€1,090 -19.6%
Furniture and vehicles 24 €16,947 €13,676 -€3,271 -19.3%
Current assets 29/58 €276,053 €389,553 +€113,500 +41.1%
Stocks and contracts in progress 3 €168,346 €166,106 -€2,239 -1.3%
Stocks 30/36 €168,346 €166,106 -€2,239 -1.3%
Amounts receivable within one year 40/41 €72,098 €146,408 +€74,311 +103%
Trade receivables 40 €63,845 €129,368 +€65,523 +103%
Other amounts receivable 41 €8,253 €17,040 +€8,788 +106%
Cash at bank and in hand 54/58 €30,683 €72,224 +€41,541 +135%
Deferred charges and accrued income 490/1 €4,927 €4,815 -€112 -2.3%
Total equity and liabilities 10/49 €1,325,564 €1,352,273 +€26,708 +2.0%
Equity 10/15 €404,745 €590,053 +€185,307 +45.8%
Contributions 10/11 €168,600 €168,600 = 0.0%
Reserves 13 €331,336 €516,643 +€185,307 +55.9%
Distributable reserves 133 €331,336 €516,643 +€185,307 +55.9%
Profit (loss) carried forward 14 -€95,191 -€95,191 = 0.0%
Amounts payable 17/49 €920,819 €762,220 -€158,599 -17.2%
Amounts payable after more than one year 17 €401,919 €335,487 -€66,432 -16.5%
Financial debts 170/4 €401,919 €335,487 -€66,432 -16.5%
Amounts payable within one year 42/48 €503,393 €404,529 -€98,864 -19.6%
Current portion of amounts payable after more than one year 42 €141,651 €66,432 -€75,219 -53.1%
Trade debts 44 €63,222 €58,907 -€4,314 -6.8%
Suppliers 440/4 €63,222 €58,907 -€4,314 -6.8%
Taxes, remuneration and social security 45 €17,286 €48,269 +€30,983 +179%
Taxes 450/3 €9,256 €36,069 +€26,814 +290%
Remuneration and social security 454/9 €8,031 €12,200 +€4,169 +51.9%
Other amounts payable 47/48 €281,233 €230,920 -€50,313 -17.9%
Accrued charges and deferred income 492/3 €15,507 €22,204 +€6,697 +43.2%
Non-recurring operating income 76A - €19 +€19
Remuneration, social security and pensions 62 €28,902 €71,508 +€42,606 +147%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €105,388 €92,016 -€13,372 -12.7%
Other operating charges 640/8 €6,300 €5,931 -€369 -5.9%
Gross operating margin 9900 €371,705 €479,479 +€107,774 +29.0%
Operating profit (loss) 9901 €231,114 €310,024 +€78,909 +34.1%
Financial income 75/76B €2,114 €1,884 -€230 -10.9%
Recurring financial income 75 €2,114 €1,884 -€230 -10.9%
Financial charges 65/66B €31,685 €39,538 +€7,853 +24.8%
Recurring financial charges 65 €31,685 €39,538 +€7,853 +24.8%
Profit (loss) for the period before taxes 9903 €201,543 €272,369 +€70,826 +35.1%
Income taxes 67/77 €63,142 €85,396 +€22,254 +35.2%
Profit (loss) for the period 9904 €138,401 €186,973 +€48,572 +35.1%
Profit (loss) for the period to be appropriated 9905 €138,401 €186,973 +€48,572 +35.1%

Value

latest balance sheet 31-03-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€914,901 to €1.2m

Midpoint €1.0m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €590,053
Capitalised earnings €1.2m to €1.7m
Indication €914,901 to €1.2m

Adjusted equity

balance sheet 31-03-2025
Equity (10/15)
€590,053
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€590,053

Capitalised earnings

net result for the year (9904)
2025
€186,973
excluding non-recurring income and charges
€186,954
2024
€138,401
2023
€195,341
2022
€64,046
2021
€61,336
Average result, excluding non-recurring income and charges
€173,565
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.2m / €1.4m / €1.7m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 14 November 2026 via checked.be.